Artigo

Preparation and characterization of a synthetic curcumin analog inclusion complex and preliminary evaluation of in vitro antileishmanial activity

Carregando...
Imagem de Miniatura

Notas

Orientadores

Editores

Coorientadores

Membros de banca

Título da Revista

ISSN da Revista

Título de Volume

Editor

Elsevier

Faculdade, Instituto ou Escola

Departamento

Programa de Pós-Graduação

Agência de fomento

Tipo de impacto

Áreas Temáticas da Extenção

Objetivos de Desenvolvimento Sustentável

Dados abertos

Resumo

Abstract

The aim of this work was to prepare and characterize inclusion complexes between a synthetic curcumin analog (dibenzalacetone, DBA) and beta-cyclodextrin (β-CD); and to evaluate their in vitro antileishmanial activity. DBA was synthetized and characterized by spectroscopic methods and the inclusion complexes were obtained by kneading and lyophilization (LIO) in 1:1 and 1:2 stoichiometries. Phase solubility and dissolution assays showed a 40-fold increase in the aqueous solubility of DBA and its complete dissolution from LIO 1:1 formulation after 120 min respectively. Solid-state characterization by differential scanning calorimetry and near infrared spectroscopy demonstrated the inclusion of DBA in the β-CD cavity at the molar ratios tested, with LIO 1:1 formulation being the most stable. Using nuclear magnetic resonance experiments, the protons inside the cavity of β-CD were the most affected after the inclusion of DBA molecule. The cellular viability of THP-1 macrophage cells treated with plain DBA, β-CD and DBA/CD inclusion complexes showed that the plain DBA and DBA/CD at 1:2 stoichiometry presented toxicity, while β-CD alone and DBA/CD at 1:1 stoichiometry showed no toxicity up to 640 μg mL−1. The in vitro assay with free-living promastigotes demonstrated that plain DBA and β-CD had IC50 of < 10 and > 320 μg mL−1 respectively, while only inclusion complexes with 1:1 stoichiometry showed antiproliferative activity with IC50 = 51.3 μg mL−1. Using the amastigote intracellular forms, there was also a difference between the plain and β-CD complexed DBA with complexes of 1:1 and 1:2 stoichiometry presenting EC50 = 66.3 μg mL−1 and 58.9 μg mL−1 respectively. The study concluded that DBA/CD at 1:1 molar ratio has the potential to decrease the intrinsic toxicity of plain DBA towards Leishmania host cells, which may be a therapeutic advantage in the application of these compounds.

Descrição

Área de concentração

Agência de desenvolvimento

Palavra chave

Marca

Objetivo

Procedência

Impacto da pesquisa

Resumen

ISBN

DOI

Citação

PINTO, L. M. A. et al. Preparation and characterization of a synthetic curcumin analog inclusion complex and preliminary evaluation of in vitro antileishmanial activity. International Journal of Pharmaceutics, Amsterdam, v. 589, 119764, 15 Nov. 2020. DOI: 10.1016/j.ijpharm.2020.119764.

Link externo

Avaliação

Revisão

Suplementado Por

Referenciado Por